From: Further evaluation of plasma sphingomyelin levels as a risk factor for coronary artery disease
Sphingomyelin‡ | ||||
---|---|---|---|---|
 | All | Cases | Controls | p-value (Z-value) |
Age, years | - 0.03 | 0.06 | -0.03 | 0.11 (1.6) |
BMI, kg/m 2 | 0.08 | 0.09 | 0.06 | 0.59 (-0.54) |
Total cholesterol, mg/dl | 0.17 | 0.25 | 0.14 | 0.04 (2.03) |
LDL cholesterol, mg/dl | 0.13 | 0.20 | 0.13 | 0.2 (1.28) |
HDL cholesterol, mg/dl | - 0.14 | -0.08 | -0.01 | 0.12 (-0.24) |
Triglyceride, mg/dl‡ | 0.31 | 0.32 | 0.11 | <0.001 (3.92) |
Apolipoprotein A-I, g/l | -0.05 | 0.05 | -0.07 | 0.03 (2.13) |
Apolipoprotein B, g/l | 0.34 | 0.36 | 0.25 | 0.03 (2.15) |
Lipoprotein(a), mg/dl | 0.03 | 0.01 | -0.04 | 0.37 (0.89) |
CETP, U/l | -0.11 | -0.03 | -0.19 | < 0.001 (2.88) |
PLTP, U/l | 0.01 | -0.06 | 0.08 | 0.01 (-2.94) |
Hs-CRP, mg/l‡ | 0.05 | 0.05 | 0.12 | 0.21 (1.25) |